FIELD: medicine; pathological physiology; extreme radiology; surgery and resuscitation.
SUBSTANCE: general uniform exposure of animals at a dose that causes the development of acute radiation injury of moderate severity is performed. The soft tissues of the thigh are injured mechanically and the femoral artery is damaged, accompanied by the development of acute massive blood loss equal to 40% of the total blood volume. After reaching the required volume of blood loss, bleeding is stopped by using a local hemostatic agent (LHA). Then, the total blood volume is replenished with saline in a volume corresponding to blood loss. The time of using the LHA is 2 hours. Then the LHA is removed from the wound, the femoral artery is ligated, and the wound is sutured in layers, followed by observation of the animals for 30 days.
EFFECT: method allows to study general biological and pathophysiological processes developing in case of radiation pathology in combination with mechanical trauma, as well as to evaluate the effectiveness of new temporary hemostasis technologies in case of combined radiation and mechanical injury including soft tissue injuries of the extremities complicated by acute massive blood loss.
1 cl, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MODELING COMBINED RADIATION-MECHANICAL DAMAGE USING NON-SURGICAL TREATMENT TACTICS | 2021 |
|
RU2762990C1 |
METHOD FOR COMBINED RADIATION MECHANICAL INJURY SIMULATION WITH POSSIBILITY TO APPLY TACTICS OF MULTI-STAGE SURGICAL TREATMENT | 2016 |
|
RU2628655C1 |
METHOD FOR SIMULATING COMBINED RADIATION MECHANICAL INJURY | 2009 |
|
RU2415477C2 |
METHOD FOR MODELING EXPLOSION INJURY OF SOFT TISSUE OF LIMB, WEIGHTENED BY BLOOD LOSS | 2020 |
|
RU2748248C1 |
METHOD OF PREVENTING BLEEDING CAUSED BY USE OF STREPTOKINASE IN EXPERIMENT | 2014 |
|
RU2552339C1 |
USE OF POLYMERIZED HEMOGLOBIN FOR MOBILIZATION OF BLOOD FROM DEPOT IN CASE OF BLOOD LOSS | 2021 |
|
RU2811253C2 |
HAEMOSTATIC COMPOSITION (EMBODIMENTS) | 2022 |
|
RU2826621C2 |
METHOD OF PREVENTION OF BLEEDING CAUSED BY THE APPLICATION OF ANTIAGREGANTS, EXPERIMENT STAGE | 2017 |
|
RU2645630C1 |
METHOD FOR PREVENTING BLEEDING CAUSED BY USE OF WARFARIN IN EXPERIMENT | 2016 |
|
RU2645414C1 |
HEMOSTATIC AGENT BASED ON CHITOSAN AEROGEL | 2020 |
|
RU2743425C1 |
Authors
Dates
2023-07-10—Published
2023-05-16—Filed